Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
ROTE WILLIAM E. (CIK 1698262) reported 21 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-17). Recent activity: Buy TVTX (39,000 shares), Buy TVTX (39,650 shares), Sell TVTX (63,907 shares), Sell TVTX (29,021 shares), Sell TVTX (3,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Buy | 39,000 | $984,750 |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Buy | 39,650 | $712,114 |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Sell | 63,907 | $4.0M |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Sell | 29,021 | $1.8M |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Sell | 3,000 | $190,952 |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Sell | 270 | $17,634 |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Buy | 350 | $6,286 |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Buy | 55,000 | $850,300 |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Buy | 57,500 | $1.5M |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Sell | 65,104 | $4.1M |
| 2026-09-17 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Sell | 47,746 | $3.0M |
| 2026-05-06 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Buy | 4,250 | $0 |
| 2026-05-06 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Sell | 2,763 | $121,434 |
| 2026-04-23 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Sell | 9,100 | $355,719 |
| 2026-04-15 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Buy | 14,000 | $0 |
| 2026-02-03 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Buy | 20,090 | $0 |
| 2026-02-03 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Sell | 12,446 | $409,100 |
| 2025-12-29 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Buy | 60,000 | $1.2M |
| 2025-12-29 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Sell | 60,000 | $2.4M |
| 2025-05-05 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Buy | 4,920 | $0 |
| 2025-05-05 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Sell | 3,198 | $67,318 |
Source: SEC Form 4 filings · as of 2026-09-17